AQR Capital Management LLC Raises Stock Position in Sabra Healthcare REIT, Inc. $SBRA

AQR Capital Management LLC raised its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 12.1% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,370,813 shares of the real estate investment trust's stock after buying an additional 147,955 shares during the quarter. AQR Capital Management LLC owned about 0.58% of Sabra Healthcare REIT worth $23,948,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of SBRA. SVB Wealth LLC purchased a new stake in shares of Sabra Healthcare REIT during the first quarter valued at about $34,000. UMB Bank n.a. lifted its position in shares of Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after buying an additional 1,621 shares during the last quarter. Wealth Preservation Advisors LLC purchased a new stake in shares of Sabra Healthcare REIT during the first quarter valued at about $38,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock valued at $49,000 after buying an additional 1,065 shares during the last quarter. Finally, Assetmark Inc. lifted its position in shares of Sabra Healthcare REIT by 37.8% during the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock valued at $63,000 after buying an additional 989 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock traded up $0.20 during midday trading on Thursday, hitting $19.13. The company had a trading volume of 1,657,545 shares, compared to its average volume of 2,442,435. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a fifty day simple moving average of $18.67 and a 200 day simple moving average of $17.93. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.59 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 1.52 and a beta of 0.88.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.36 by $0.02. The business had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is 157.89%.

Analysts Set New Price Targets

Several research firms have commented on SBRA. Truist Financial increased their price target on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research report on Tuesday, September 2nd. Scotiabank increased their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. BMO Capital Markets increased their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. Finally, JMP Securities increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $20.71.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.